AbbVie bonds
6 USD bonds tracked for AbbVie, maturing 2028–2049. Yields to worst 5.1–6.3% on 20 Nov 2026. Compare dated prices, yields and scheduled payments.
Legal name: AbbVie Inc.
6 tracked issues for AbbVie Inc., denominated in USD. Scheduled final maturities range from 14 NOV 28 to 21 NOV 49. Recorded governing law: NY.
Updated 20 NOV 26.
Figures cover the bonds listed on this page.
Bond prices, yields and maturities
| Bond | ISIN | Currency | Price per 100 | Yield to worst (S.A.) | Coupon | Maturity | Price date | G-spread (bps) | Modified duration (years) | Outst (USDm) | Seniority | Curve coverage |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AbbVie 4.25% 2028 · ABBV 4.25 28 | US00287YBF51 | USD | 98.370 | 5.12% | 4.25% | 14 NOV 28 | 19 NOV 26 | 36.0 | 1.88 | 1,750 | Not documented | Included in fit |
| AbbVie 4.8% 2029 · ABBV 4.8 29 | US00287YDS54 | USD | 99.260 | 5.14% | 4.8% | 15 MAR 29 | 19 NOV 26 | 37.0 | 2.08 | 2,500 | Registered users | Included in fit |
| AbbVie 3.2% 2029 · ABBV 3.2 29 | US00287YBX67 | USD | 94.360 | 5.25% | 3.2% | 21 NOV 29 | 19 NOV 26 | 44.0 | 2.76 | 5,500 | Registered users | Included in fit |
| AbbVie 4.95% 2031 · ABBV 4.95 31 | US00287YDT38 | USD | 98.490 | 5.34% | 4.95% | 15 MAR 31 | 19 NOV 26 | 50.0 | 3.81 | 2,000 | Registered users | Included in fit |
| AbbVie 4.5% 2035 · ABBV 4.5 35 | US00287YAR09 | USD | 92.030 | 5.70% | 4.5% | 14 MAY 35 | 19 NOV 26 | 71.0 | 6.87 | 2,500 | Registered users | Included in fit |
| AbbVie 4.25% 2049 · ABBV 4.25 49 | US00287YCB39 | USD | 75.660 | 6.26% | 4.25% | 21 NOV 49 | 19 NOV 26 | 84.0 | 12.80 | 5,750 | Registered users | Included in fit |
Next scheduled payments
- 23 NOV 26 · coupon · ABBV 3.2 29 · USD 88 million
- 23 NOV 26 · coupon · ABBV 4.25 49 · USD 122 million
- 15 MAR 27 · coupon · ABBV 4.8 29 · USD 60 million
- 15 MAR 27 · coupon · ABBV 4.95 31 · USD 49.5 million
- 14 MAY 27 · coupon · ABBV 4.5 35 · USD 56.3 million
- 14 MAY 27 · coupon · ABBV 4.25 28 · USD 37.2 million
Scheduled principal by year
Scheduled principal repayments for the listed bonds.
| Year | Principal |
|---|---|
| 2028 | USD 1,750 million |
| 2029 | USD 8,000 million |
| 2031 | USD 2,000 million |
| 2035 | USD 2,500 million |
| 2049 | USD 5,750 million |
Credit ratings & history
Credit ratings
- AbbVie Inc. · Moody’s · Long-term issuer · Global
Rating: A2 · Recorded 29 OCT 26 · Rating source
Outlook: Stable · Recorded 29 OCT 26 · Outlook source - AbbVie Inc. · S&P · Long-term issuer · Global
Rating: A- · Recorded 29 OCT 26 · Rating source
Outlook: Positive · Recorded 29 OCT 26 · Outlook source
Rating & credit history
No credit history available.
History may be incomplete. “Recorded” dates indicate when we saved the rating.